Edition:
United Kingdom

Cellectis SA (CLLS.OQ)

CLLS.OQ on NASDAQ Stock Exchange Global Market

12.82USD
19 Aug 2019
Change (% chg)

$0.53 (+4.31%)
Prev Close
$12.29
Open
$12.78
Day's High
$12.82
Day's Low
$12.65
Volume
5,517
Avg. Vol
35,214
52-wk High
$29.95
52-wk Low
$11.70

About

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid... (more)

Overall

Beta: --
Market Cap(Mil.): $1,013.89
Shares Outstanding(Mil.): 35.42
Dividend: --
Yield (%): --

Financials

  CLLS.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -2.24 -- --
ROI: -27.62 8.94 14.48
ROE: -27.69 10.07 15.78

BRIEF-Cellectis Reports New CAR Design To Control T-Cells

* REPORTED ON MONDAY NEW CAR DESIGN TO CONTROL CAR T-CELLS IN NON-LETHAL WAY

09 Jul 2019

BRIEF-Cellectis Q4 Operating Loss Widens To 29.3 Million Dollars

* ANNOUNCED ON MONDAY, CELLECTIS REPORTS 4TH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS

12 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates